Role of Tim Family Genes in Asthma and Allergic Diseases
Role of Tim Family Genes in Asthma and Allergic Diseases
批准号:
7118424
负责人:
DALE T UMETSU
金额:
$143.94万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2008-03-31
中文摘要
描述(由申请人提供):本项目的总体目标是阐明我们最近发现的一个名为Tims的新基因家族在哮喘发病机制中的作用。Tim基因似乎在调节CD4 T细胞分化和过敏原诱导的气道高反应性发展中起关键作用。此外,我们假设Tim基因的人类同源基因是哮喘易感基因,因为它们位于染色体5q33.2上,这是一个与哮喘反复相关的区域,并且显示出显著的序列多态性。此外,人类Tim1编码甲型肝炎病毒(HAV)的受体,这表明CD4 T细胞和TIM-1介导了已知的甲型肝炎病毒感染对特应性发展的保护作用。由于甲型肝炎感染的患病率在工业化国家大大降低,我们的研究结果可能解释了过去几十年来哮喘患病率的增加,并强烈建议Tim1在直接调节人类哮喘和过敏的发展中起主要作用。
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this Program Project is to elucidate the role of a novel family of genes that we recently discovered called Tims, in the pathogenesis of asthma. The Tim genes appear to play a critical role in regulating CD4 T cell differentiation and the development of allergen-induced airway hyperreactivity. In addition, we hypothesize that the human homologues of the Tim genes are asthma susceptibility genes, since they lie on chromosome 5q33.2, a region repeatedly linked to asthma, and display significant sequence polymorphisms. Moreover, the human Tim1 encodes the receptor for the hepatitis A virus (HAV), suggesting that CD4 T cells and TIM-1 mediate the known protective effect of prior infection with HAV on the development of atopy. Since the prevalence of HAV infection is greatly reduced in industrialized countries, our findings may explain the increase in asthma prevalence occurring over the past decades, and strongly suggest that Tim1 plays a major role in directly regulating the development of human asthma and allergy.
The proposed studies will examine several members of the Tim gene family in both human and murine systems. In Project 1, headed by Dale T. Umetsu, we will perform association analysis to determine if Tim1 and Tim3 gene polymorphisms are associated with asthma, allergy, specific IgE, or elevated total IgE. We will also analyze the cellular and molecular processes that occur when HAV binds to TIM-1 on T lymphocytes, and determine how HAV infection alters CD4 T cell differentiation and prevents the development of asthma. In Project 2, headed by Gordon J. Freeman, we will examine the expression pattern of human TIM-1 and TIM-3, and examine the function of human TIM-1 and TIM-3 using TIM-1 and TIM-3 fusion proteins, as well as antibody directed against these proteins. In addition, we will characterize the ligand for TIM-3 and TIM-1. In Project 3, headed by Rosemarie H. DeKruyff, we will utilize a murine system with Tim1 knockout mice and TIM blocking reagents to directly study the precise role of TIM-1 in the development of Th2 responses and allergen-induced airway hyperreactivity.
This Program Project brings together a group of very strong immunologists, who have worked closely together for many years, along with an outstanding geneticist and virologist. Together, these investigators have a very strong record of accomplishment in asthma and allergy, cloning genes and their ligands, and in investigating the genetics of complex disease. These studies of Tim genes will characterize a very important human asthma susceptibility gene, and provide extraordinary insight into genetic, immunologic and environmental pathways involved in asthma pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting innate lymphoid cells during influenza virus-induced asthma
-
批准号:8566307
-
项目类别:
-
资助金额:$16.94万
-
财政年份:2012
-
负责人:DALE T UMETSU
-
依托单位:
Peanut Glycolipid Antigens Activate Natural Killer T Cells Causing Severe Allergy
-
批准号:8044035
-
项目类别:
-
资助金额:$18.83万
-
财政年份:2010
-
负责人:DALE T UMETSU
-
依托单位:
Peanut Glycolipid Antigens Activate Natural Killer T Cells Causing Severe Allergy
-
批准号:7877661
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2010
-
负责人:DALE T UMETSU
-
依托单位:
NKT cells recognize and respond to microbes at mucosal surfaces
-
批准号:7706862
-
项目类别:
-
资助金额:$25.08万
-
财政年份:2009
-
负责人:DALE T UMETSU
-
依托单位:
Recognition of microbes by NKT cells at the lung mucosal surface
-
批准号:7822608
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2009
-
负责人:DALE T UMETSU
-
依托单位:
Recognition of microbes by NKT cells at the lung mucosal surface
-
批准号:7935423
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2009
-
负责人:DALE T UMETSU
-
依托单位:
NKT cells recognize and respond to microbes at mucosal surfaces
-
批准号:7897764
-
项目类别:
-
资助金额:$19.45万
-
财政年份:2009
-
负责人:DALE T UMETSU
-
依托单位:
Mechanisms by which Influenza A Protects Against Asthma
-
批准号:6913268
-
项目类别:
-
资助金额:$23.59万
-
财政年份:2005
-
负责人:DALE T UMETSU
-
依托单位:
Mechanisms by Which Influenza A Protects Against Asthma
-
批准号:7449665
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2005
-
负责人:DALE T UMETSU
-
依托单位:
Mechanisms by Which Influenza A Protects Against Asthma
-
批准号:7185842
-
项目类别:
-
资助金额:$44.8万
-
财政年份:2005
-
负责人:DALE T UMETSU
-
依托单位:
Mechanisms by Which Influenza A Protects Against Asthma
-
批准号:7107940
-
项目类别:
-
资助金额:$46.14万
-
财政年份:2005
-
负责人:DALE T UMETSU
-
依托单位:
HETEROGENEITY AMONG HUMAN CD4+ T CELL CLONES
-
批准号:7202010
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2004
-
负责人:DALE T UMETSU
-
依托单位:
XOLAIR IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS WITH FOOD ALLERGY
-
批准号:7202106
-
项目类别:
-
资助金额:$1.27万
-
财政年份:2004
-
负责人:DALE T UMETSU
-
依托单位:
Role of Tim Family Genes in Asthma and Allergic Diseases
-
批准号:6599037
-
项目类别:
-
资助金额:$70.73万
-
财政年份:2003
-
负责人:DALE T UMETSU
-
依托单位:
Heterogeneity Among Human CD4+ T Cell Clones
-
批准号:6980880
-
项目类别:
-
资助金额:$2.87万
-
财政年份:2003
-
负责人:DALE T UMETSU
-
依托单位:
Administration
-
批准号:8507124
-
项目类别:
-
资助金额:$15.65万
-
财政年份:2003
-
负责人:DALE T UMETSU
-
依托单位:
NKT cells activated by apoptotie cells through TIM-1 regulate asthma
-
批准号:8507122
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2003
-
负责人:DALE T UMETSU
-
依托单位:
NKT cells activated by apoptotie cells through TIM-1 regulate asthma
-
批准号:7995551
-
项目类别:
-
资助金额:$26.7万
-
财政年份:2003
-
负责人:DALE T UMETSU
-
依托单位:
Administration
-
批准号:8866347
-
项目类别:
-
资助金额:$11.28万
-
财政年份:2003
-
负责人:DALE T UMETSU
-
依托单位:
NKT cells activated by apoptotie cells through TIM-1 regulate asthma
-
批准号:8306824
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2003
-
负责人:DALE T UMETSU
-
依托单位:
国内基金
海外基金
大鱼际掌纹特应征与5个哮喘易感基因单核苷酸多态性的关联分析
-
批准号:30873315
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:周兆山
-
依托单位:
调节性T细胞和共刺激分子在过敏原早期暴露诱导哮喘免疫耐受中的作用机制研究
-
批准号:30740048
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2007
-
负责人:李海潮
-
依托单位:
CBP介导STAT4/STAT6相互拮抗在哮喘Th失衡中的机制
-
批准号:30672268
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2006
-
负责人:符州
-
依托单位: